Company intelligence / Profile preview

HitGen

Chengdu City, Sichuan Province, Chinalinkedin.com ↗

Ownership: Private
Development stage: Phase 1

Overview

HitGen has established itself as a global leader in DNA encoded library technology for drug discovery. The company has advanced multiple programs from early discovery to clinical trial stage, with four having reached IND/clinical status as of mid-2022. Its DEL platform contains over 1.2 trillion compounds and supports collaborations with hundreds of biopharma partners worldwide.

Therapeutic areas: Oncology
Modalities: Small moleculesnucleic acid drugs (including oligonucleotides)macrocyclic compounds
Industry: Drug Discovery Services

Drug pipeline

7 assets

HG146

Clinical Trials

Indications: Multiple myeloma, Solid tumor

6 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with several hundred biopharmaceutical research organizations globally.Notable partnership example includes Bridge Biotherapeutics for anti-cancer drug development.Additional partnerships span pharmaceutical, biotech, chemical companies, foundations, and research institutes across all continents except Antarctica.

Beyond the preview

Go deeper on HitGen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on HitGen.

Explore the full profile